Sign in
4

Changes in Ownership

Yarrow Bioscience, Inc. Filed Acc 0001415889-24-015370

PRESIDENT AND CEO acquired 4,429 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Domzalski David · PRESIDENT AND CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-05-31 Grant or award : show line 1 in the form +4,429 $2.16 $9,562 498,589 D
Loading xslF345X05/form4-06042024_040620.xml…